The Center for Breakthrough Medicines (CBM), a cell and gene therapy contract developer and manufacturer at King of Prussia’s Discovery Labs, said this week it had added four women to its leadership team. The appointments play a “critical role in bringing the facilities online to deliver real solutions to advanced therapy developers,” the org said in a statement…

Read full story